Nogaret JM - Search Results

1

Recurrence dynamics of breast cancer according to baseline body mass index.

Biganzoli E, Desmedt C, Fornili M, de Azambuja E, Cornez N, Ries F, Closon-Dejardin MT, Kerger J, Focan C, Di Leo A, Nogaret JM, Sotiriou C, Piccart M, Demicheli R. Biganzoli E, et al. Among authors: nogaret jm. Eur J Cancer. 2017 Dec;87:10-20. doi: 10.1016/j.ejca.2017.10.007. Epub 2017 Oct 31. Eur J Cancer. 2017. PMID: 29096156 Clinical Trial.

2

Expression of c-erbB2, TGF-beta 1 and pS2 genes in primary human breast cancers.

Delvenne CG, Winkler-Gol RA, Piccart MJ, Hustin J, Michaux D, Leclercq G, Nogaret JM, Autier P. Delvenne CG, et al. Among authors: nogaret jm. Eur J Cancer. 1992;28(2-3):700-5. doi: 10.1016/s0959-8049(05)80130-3. Eur J Cancer. 1992. PMID: 1350458

3

Cisplatin combined with carboplatin: a new way of intensification of platinum dose in the treatment of advanced ovarian cancer. Belgian Study Group for Ovarian Carcinoma.

Piccart MJ, Nogaret JM, Marcelis L, Longrée H, Ries F, Kains JP, Gobert P, Domange AM, Sculier JP, Gompel C. Piccart MJ, et al. Among authors: nogaret jm. J Natl Cancer Inst. 1990 Apr 18;82(8):703-7. doi: 10.1093/jnci/82.8.703. J Natl Cancer Inst. 1990. PMID: 2181152

4

[Current status and future of diagnosis and therapy of breast cancer: introduction].

Nogaret JM. Nogaret JM. Rev Med Brux. 1995 Jul-Aug;16(4):211-3. Rev Med Brux. 1995. PMID: 7481225 French.

5

[Male breast cancer].

Veys I, Nogaret JM. Veys I, et al. Among authors: nogaret jm. Rev Med Brux. 1995 Dec;16(6):394-6. Rev Med Brux. 1995. PMID: 8570980 French.

6

[Optimal therapeutic strategies in ovarian epithelial cancer in 1997].

Piccart MJ, Nogaret JM. Piccart MJ, et al. Among authors: nogaret jm. Rev Med Brux. 1997 Sep;18(4):198-203. Rev Med Brux. 1997. PMID: 9411642 Review. French.

7

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.

Di Leo A, Crown J, Nogaret JM, Duffy K, Bartholomeus S, Dolci S, Rowan S, O'Higgins N, Paesmans M, Larsimont D, Riva A, Piccart MJ. Di Leo A, et al. Among authors: nogaret jm. Ann Oncol. 2000 Feb;11(2):169-75. doi: 10.1023/a:1008345432342. Ann Oncol. 2000. PMID: 10761751 Free article. Clinical Trial.

8

Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases.

Gancberg D, Lespagnard L, Rouas G, Paesmans M, Piccart M, Di Leo A, Nogaret JM, Hertens D, Verhest A, Larsimont D. Gancberg D, et al. Among authors: nogaret jm. Am J Clin Pathol. 2000 May;113(5):675-82. doi: 10.1309/0F58-0GRX-FK4R-A6VA. Am J Clin Pathol. 2000. PMID: 10800400

9

Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.

Piccart MJ, Di Leo A, Beauduin M, Vindevoghel A, Michel J, Focan C, Tagnon A, Ries F, Gobert P, Finet C, Closon-Dejardin MT, Dufrane JP, Kerger J, Liebens F, Beauvois S, Bartholomeus S, Dolci S, Lobelle JP, Paesmans M, Nogaret JM. Piccart MJ, et al. Among authors: nogaret jm. J Clin Oncol. 2001 Jun 15;19(12):3103-10. doi: 10.1200/JCO.2001.19.12.3103. J Clin Oncol. 2001. PMID: 11408507 Clinical Trial.

10

3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot study.

Ferreira Filho AF, Crown J, Cardoso F, Nogaret JM, Duffy K, Dolci S, Rowan S, O'Higgins N, Batter V, Paesmans M, Piccart MJ, Di Leo A. Ferreira Filho AF, et al. Among authors: nogaret jm. Anticancer Res. 2002 Jul-Aug;22(4):2471-6. Anticancer Res. 2002. PMID: 12174946 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page